A dapsone-induced blood dyscrasia in the mouse: Evidence for the role of an active metabolite

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 2, 1996, Pages 228-232

  Ahmadi, M ^a   Khalaf, L F ^a   Smith, H J ^a   Nicholls, P J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CYTOCHROME P450; DAPSONE; METHEMOGLOBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD DYSCRASIA; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; ERYTHROCYTE; FEMALE; LEUKOCYTE COUNT; LIVER MICROSOME; METHEMOGLOBINEMIA; MONONUCLEAR CELL; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; THROMBOCYTE COUNT;

EID: 0029871024     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb07129.x     Document Type: Conference Paper

References (29)

1. Ali, H., Nicholls, P. J. (1986) Haematological effects of aminoglutethimide in the mouse. J. Pharm. Pharmacol. 38: 92P
2. Ali, H , Khalaf, L., Nicholls, P. J., Poole, A. (1990) Comparison of in vitro and in vivo haemotoxic effects of aminoglutethimide and glutethimide. Toxicology In Vitro 4: 381-383
3. Ali, H. (1987) Ph.D. Thesis. University of Wales
4. Archer, R. K. (1965) Haematological Techniques of Use on Animals (2nd edn) Blackwell, Oxford
5. Butler, M. A., Iwasaki, M., Guengerich, F. P., Kadlubar, F. F. (1989) Human cytochrome P-450PA (P-450IA2), the phenacetin O-de-ethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA 86: 7696-7700
6. Coleman, M. D., Tingle, M. D. (1992) Use of a metabolic inhibitor to reduce dapsone-dependent haematological toxicity. Drug Dev. Res. 15: 1-16
7. Coleman, M. D., Breckenridge, A. M., Park, B. K. (1989) Bioactivation of dapsone to a cytotoxic metabolite by human hepatic microsomal enzymes. Br. J. Clin. Pharmacol. 28: 389-395
8. Coleman, M. D., Rhodes, L. A., Scott, A. K., Verbov, J. L., Friedman, P. S., Breckenridge, A. M., Park, B. K. (1992) The use of cimetidine to reduce dapsone-dependent methaemoglobinaemia in dermatitis herpetiformis patients Br. J. Clin. Pharmacol. 34: 244-249
9. Coleman, M. D., Scott, A. K., Breckenridge, A. M., Park, B. K. (1990a) The use of cimetidine as a selective inhibitor of dapsone N-hydroxylation in man. Br. J. Clin. Pharmacol. 30: 761-767
10. Coleman, M. D., Simpson, J., Jacobus, D. P. (1994) Reduction of dapsone hydroxylamine to dapsone during methaemoglobin formation in human erythrocytes in vitro, IV: implications for the development of agranulocytosis. Biochem. Pharmacol. 48: 1349-1354
11. Coleman, M. D., Winn, M. J., Breckenridge, A. M., Park, B. K. (1990b) Sex-dependent sensitivity to dapsone-induced methaemoglobinaemia in the rat. Biochem. Pharmacol. 39: 805-809
12. Cooper, J. R., Axelrod, J., Brodie, B. B. (1954) Inhibitory effects of β-diethylaminoethyldiphenylpropylacetate on a variety of drug metabolic pathways in vitro. J. Pharmacol. Exp. Ther. 112: 55-63
13. Cucinell, S. A., Israeli, Z. H., Dayton, P. G. (1972) Microsomal N-oxidation of dapsone as a cause of methaemoglobin formation in human red cells. Am. J. Tropical Med. Hyg. 21: 322-331
14. Dalrymple, P. D., Nicholls, P. J. (1988) Metabolism profiles and excretion of 14C-aminoglutethimide in several animal species and man. Xenobiotica 18: 75-81
15. Fairbanks, V. F. (1976) Hemoglobin, hemoglobin derivatives and myoglobin. In: Tietz, N.W. (ed.) Fundamentals of Clinical Chemistry. Saunders, Philadelphia
16. Fleming, C. M., Branch, R. A., Wilkinson, G. R., Guengerich, F, P. (1992) Human liver microsomal N-hydroxylation of dapsone by cytochrome P-4503A4. Mol. Pharmacol. 41: 975-980
17. Friman, G., Nystrom-Rosander, C., Jonsell, G., Bjorkman, A., Lekas, G., Sendsrup, B. N. (1983) Agranulcytosis associated with malaria prophylaxis with Maloprim. Br. Med. J. 286: 1244-1245
18. Knodell, R. G., Browne, D. G., Gwozdz, G. P., Brian, W. R., Guengerich, F. P. (1991) Differential inhibition of individual human liver, cytochromes P-450 by cimetidine. Gastroenterology 101: 1680-1691
19. Kramer, P. A., Glader, B. E., Li, T. K. (1972) Mechanism of methemoglobin formation by diphenylsulfones. Effect of 4-amino-4′-hydroxyaminodiphenylsulfone and other p-substituted derivatives. Biochem. Pharmacol. 21: 1265-1274
20. Lee, B. L., Medina, I., Benowitz, N. L., Jacob, P., Wofsy, C. B., Mills, J. (1989) Dapsone, trimethoprim and sulfamethizole plasma levels during treatment of pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 110: 606-611
21. McLean, S., Robinson, J., Starmer, G. A., Thomas, J. (1967) The influence of anaesthetic agents on the formation of methaemoglobin induced by aniline in cats. J. Pharm. Pharmacol. 19: 803-809
22. Messeih, A. A., Lipton, A., Santen, R. J., Harvey, H. A., Boucher, A. E., Murray, R., Ragaz, J., Buzdar, A U., Nagel, G. A., Henderson, I. C. (1985) Aminoglutethimide-induced haematologic toxicity : world-wide experience. Cancer Treat. Reports 69: 1003-1004
23. Omura, T., Sato, R. (1964) The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem. 221: 253-264
24. Riley, R. J., Maggs, J. L., Lambert, C., Kitteringham, N. R., Park, B. K. (1988) An in vitro study of the microsonal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin. Br. J. Clin. Pharmacol. 26: 577-588
25. Singleton, S. D., Murphy, S. D. (1973) Propanil (3,4-dichloropro-pionanilide)-induced methaemoglobin formation in mice in relation to acylamidase activity. Toxicol. Appl. Pharmacol. 25: 20-29
26. Smith, R. P., Alkaitis, A. A., Schafer, P. R. (1967) Chemically induced methemoglobinemias in the mouse. Biochem. Pharmacol. 16: 317-328
27. Uehleke, H. (1972) In: Bridges J. W., Gorrod, J. W., Parke, D. V. (eds) Biological Oxidation of Nitrogen in Organic Molecules. Taylor and Francis, London
28. Yamasaki, H., Degawn, M., Funae, Y., Imaoka, S., Inui, T., Guengerich, F. P. (1991) Roles of different cytochrome P450 enzymes in bioactivation of the potent hepatocarcinogen 3-methoxy-4-aminoazobenzene by rat and human liver microsomes. Carcinogenesis 12: 133-139
29. Zuidema, J., Hilbers-Modderman, E. S. M., Markus, F. W. H. M. (1986) Clinical Pharmacokinetics of dapsone. Clin. Pharmacokin. 11: 299-325